Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
July 30, 2024 16:10 ET
|
Oculis Holding AG
ZUG, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today...
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
July 30, 2024 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Pacira BioSciences Reports Second Quarter 2024 Financial Results
July 30, 2024 16:00 ET
|
Pacira BioSciences
-- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain...
Verana Health and HealthVerity Partner to Advance Use of Real-World Evidence in Research
July 30, 2024 09:00 ET
|
Verana Health, Inc.
SAN FRANCISCO, July 30, 2024 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today...
Global Regenerative Medicine Market Size To Worth USD 349.93 Billion By 2033 | CAGR of 27.06%
July 30, 2024 02:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, July 30, 2024 (GLOBE NEWSWIRE) -- The Global Regenerative Medicine Market Size is to Grow from USD 31.90 Billion in 2023 to USD 349.93 Billion by 2033, at a Compound Annual...
European Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO)
July 30, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept, and robust retinal...
Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China
July 29, 2024 16:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., July 29, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.
July 29, 2024 07:35 ET
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced the signing of a co-promotion agreement with Kowa Pharmaceuticals America, Inc.
Claritas HealthTech Announces Spin-Off of Claritas NucMed Technologies Ltd to Lead Global Delivery of its Suite of Software Solutions in Nuclear Medicine
July 29, 2024 07:30 ET
|
Claritas HealthTech Ltd
Claritas HealthTech Announces Spin-Off of Claritas NucMed Technologies Ltd to Lead Global Delivery of its Suite of Software Solutions in Nuclear Medicine
Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results
July 29, 2024 07:02 ET
|
Ocugen
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...